ACTAVIS MID ATLANTIC FDA Approval ANDA 075067

ANDA 075067

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #075067

Documents

Letter1999-07-19
Review1999-07-19

Application Sponsors

ANDA 075067ACTAVIS MID ATLANTIC

Marketing Status

Discontinued001

Application Products

001SOLUTION;INHALATION10MG/ML0CROMOLYN SODIUMCROMOLYN SODIUM

FDA Submissions

ORIG1AP1999-07-19
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2000-03-28
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2001-04-03
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2002-02-20
LABELING; LabelingSUPPL6AP2005-01-06

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75067
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CROMOLYN SODIUM","activeIngredients":"CROMOLYN SODIUM","strength":"10MG\/ML","dosageForm":"SOLUTION;INHALATION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CROMOLYN SODIUM","submission":"CROMOLYN SODIUM","actionType":"10MG\/ML","submissionClassification":"SOLUTION;INHALATION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.